课题基金 / 基金详情

Identification of the binding domain of Plasmodium falciparum erythrocyte binding protein.

Identification of the binding domain of Plasmodium falciparum erythrocyte binding protein.
恶性疟原虫红细胞结合蛋白结合域的鉴定。
批准号:
16390126
负责人:
TORII Motomi
金额:
$9.66万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (B)
财政年份:
2004
资助国家:
日本
项目状态:
已结题
起止时间:
2004 至 2005

项目摘要

项目成果

TORII Motomi的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Invasive form of Plasmodium falciparum malaria parasite possesses microorganelle, called Rhoptry, at its apex, from which erythrocyte binding protein RhopH complex (comprising RhopH1, RhopH2, and RhopH3) is discharged and considered to have essential role, because of the failure of attempt to disrupt gene locus. We showed that this complex binds erythrocyte surface via protein and GPI-anchor dependent manner, but the precise mechanism is still unknown. Thus, in this project, we generated genetically manipulated Plasmodium falciparum, which express a part of RhopH complex fused with GFP and asked if each chimeric protein have erythrocyte binding ability. To this end, we generated 4 parasite lines possessing plasmids which would express 1/3 of RhopH1, 2/3 of RhopH1, full length of RhopH1 fused with GFP, or GFP alone under the rhoptry protein promoter. However, we could observe GFP signal only from parasite for 1/3 of RhopH1 and GFP only. The reason why GFP signal is not detected from parasites with 2/3 or full length of RhopH1 is unknown, but we speculate that this maybe because of the relatively large plasmid size. Interestingly, parasite expressing GFP fused with only signal peptide of the RhopH2 showed rhoptry localization of GFP. This indicates that the default destination of the protein with signal peptide could be rhoptry among multipel microorganelle. Immunoprecipitation against RhopH2 did not co-purify 1/3 of RhopH1 plus GFP, indicating this part is not responsible for the RhopH complex formation. Also, we could not observe erythrocyte binding ability for this 1/3 of RhopH1 chimeric protein, suggesting that this region may not be the binding domain.
期刊论文(14)
专著(0)
科研奖励(0)
会议论文
DOI: 10.1128/iai.72.6.3604-3608.2004
发表时间: 2004-06-01
期刊: INFECTION AND IMMUNITY
影响因子: 3.1
作者: [Preiser, P, Rénia, L, Adams, JH]
通讯作者: Adams, JH
DOI: 10.1016/j.molbiopara.2006.02.018
发表时间: 2006-07-01
期刊: MOLECULAR AND BIOCHEMICAL PARASITOLOGY
影响因子: 1.5
作者: [Yano, Kazuhiko, Komaki-Yasuda, Kanako, Kawazu, Shin-ichiro]
通讯作者: Kawazu, Shin-ichiro
Nasal immunization with a malaria transmission-blocking vaccine candidate Pfs25 induces complete protective immunity in mice against field-isolated Plasmodium falciparum
使用阻断疟疾传播的候选疫苗 Pfs25 进行鼻免疫可诱导小鼠针对现场隔离的恶性疟原虫产生完全保护性免疫力
DOI: --
发表时间: 2005
期刊: Infection and Immunity 73
影响因子: --
作者: [Arakawa T, et. al.]
通讯作者: et. al.
The Plasmodium falciparum clag 9 gene encodes a rhoptry protein.
恶性疟原虫 clag 9 基因编码一种菱形蛋白。
DOI: --
发表时间: 2004
期刊: Mol Microb 52(1)
影响因子: --
作者: [Ishii T., Yasuda K., Akatsuka A., Hino O., Hartman P.S., Ishii N., Kaneko O et al., Winter G et al., Hino O., Arakawa T et al., Rungruang T et al., Ling IT et al.]
通讯作者: Ling IT et al.
9
    Development of novel transmission blocking vaccine targeting microgamete surface antigen of Plasmodium falciparum
    • 批准号:
      20H03480
    • 项目类别:
      Grant-in-Aid for Scientific Research (B)
    • 资助金额:
      $11.32万
    • 财政年份:
      2020
    • 负责人:
      TORII Motomi
    • 依托单位:
    Assessment of P. vivax transmission-blocking activity of novel vaccine candidate (PvGs24)
    • 批准号:
      16H05816
    • 项目类别:
      Grant-in-Aid for Scientific Research (B)
    • 资助金额:
      $11.32万
    • 财政年份:
      2016
    • 负责人:
      TORII Motomi
    • 依托单位:
    Development of novel P. falciparum malaria transmission-blocking vaccine targeted against Pf75
    • 批准号:
      15H04725
    • 项目类别:
      Grant-in-Aid for Scientific Research (B)
    • 资助金额:
      $10.98万
    • 财政年份:
      2015
    • 负责人:
      TORII Motomi
    • 依托单位:
    Development of novel malaria transmission blocking vaccine
    • 批准号:
      21406010
    • 项目类别:
      Grant-in-Aid for Scientific Research (B)
    • 资助金额:
      $11.23万
    • 财政年份:
      2009
    • 负责人:
      TORII Motomi
    • 依托单位:
    国内基金
    海外基金
    PfAP2-R介导的PfCRT转录调控在恶性疟原虫对喹啉类药物抗性中的作用及机制研究
    GC Malaria - 利用按蚊天然抗疟共生菌阻断疟疾传播
    户外杀蚊真菌农药研制(GC Malaria)
    • 批准号:
      82261128004
    • 项目类别:
      国际(地区)合作与交流项目
    • 资助金额:
      150.00万元
    • 批准年份:
      2022
    • 负责人:
      彭国雄
    • 依托单位:
    GC Malaria:研发昆虫不育技术用于控制城市疟疾媒介斯氏按蚊
    • 批准号:
      82261128006
    • 项目类别:
      国际(地区)合作与交流项目
    • 资助金额:
      130.00万元
    • 批准年份:
      2022
    • 负责人:
      张东京
    • 依托单位: